Verdict · sk:mood

Is 5-HTP worth it?

SKIP IT

5-HTP has a plausible serotonin mechanism, but the clinical evidence for mood is old and too thin, and the sleep pitch is even less settled. The downside is not theoretical for real shoppers: combining serotonin precursors with serotonergic drugs can create a serious serotonin-toxicity problem. This is a skip unless a clinician is deliberately supervising it.

The call

The best-known Cochrane review found that only a very small fraction of located depression trials were reliable enough to include, and the authors judged the evidence insufficient for broad use. That leaves a plausible neurotransmitter story without the modern, high-quality clinical base expected for a mood supplement. Sleep marketing leans on serotonin-to-melatonin biology, but that is not the same as a dependable insomnia outcome. Because many likely buyers are already using antidepressants, migraine drugs, pain medicines, cough medicines, or other serotonergic products, the risk-benefit profile is poor for unsupervised use.

Safety

Do not combine 5-HTP with SSRIs, SNRIs, MAOIs, tricyclic antidepressants, trazodone, serotonergic migraine drugs, tramadol, meperidine, linezolid, methylene blue, dextromethorphan, MDMA, lithium, St. John's wort, SAMe, or other serotonin-raising products unless a clinician explicitly directs it. Avoid in pregnancy, breastfeeding, children, bipolar disorder or mania risk, severe depression, suicidal ideation, liver disease, kidney disease, and before surgery. Common side effects include nausea, diarrhea, abdominal pain, heartburn, drowsiness, vivid dreams, headache, agitation, sweating, tremor, and palpitations. Seek urgent care for confusion, fever, muscle rigidity, clonus, severe agitation, fast heart rate, unstable blood pressure, or severe diarrhea because those can fit serotonin toxicity.

Dose that matters: No recommended self-directed mood or sleep dose. Commercial products often sell 50-100 mg, commonly at night, but that is not a proven sleep protocol; older clinical depression protocols were medication-like and should not be copied around antidepressants or other serotonergic drugs.

Sources

Tier 1 · evidence synthesis · Reviewed by the Stack-kit desk

Audit your whole shelf →   See all verdicts →

Goals